A multicultural group practicing yoga together in a bright studio

Direct Meds vs Embody: GLP-1 Comparison 2026

Direct Meds vs Embody: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Both programs’ prices verified July 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated September 17, 20264 min read

Quick answer

Direct Meds and Embody both offer GLP-1 telehealth, but they package medication, support, and pricing differently. The right choice depends on whether you weight cost, clinical touch, or formulation flexibility highest.

Side-by-side comparison

Feature	Direct Meds	Embody
Best for	Multiple compounded formats (injection and sublingual)	Personalized compounded blends and hands-on support
Medication type	Compounded semaglutide and tirzepatide	Compounded GLP-1 with personalization
Pricing model	All-inclusive monthly price by medication format	Monthly subscription, formulation-tiered
Semaglutide price	From $249/mo (sublingual) to $297/mo (injection), all-inclusive, verified 2026-07-25 on Direct Meds' own product pages ('$249.00 / month … Billed Every Month', '0% OFF')	Compounded, $69/mo (limited-time promo; the offer page shows a 'Was $299' strikethrough and a 'Fall Sale Discount Applied!' banner as of 2026-09-17, with an expired-reading countdown), verified 2026-09-17; confirm current price at checkout
Tirzepatide price	From $299/mo (sublingual) to $399/mo (injection), all-inclusive, verified 2026-07-25	Compounded tirzepatide / GLP-1+GIP, $119/mo (flat pricing shown on the verified offer page), verified 2026-09-17; no 'was' comparison price shown for tirzepatide specifically, confirm at signup.
Key watchout	Pricing varies by format and page, product-page 'all-inclusive' rates differ from homepage promo cards; confirm your format's rate at checkout	Embody's published price is a live time-limited promo with no confirmed standing rate: it changed intra-day on 2026-07-14 ($99/mo AM, '$200 OFF, was $299', to $149/mo PM, '$150 OFF, was $299'), and by 2026-08-21 the same offer URL had dropped further to a new low. We rank it at its current verified purchasable price ($69/mo semaglutide) and label it a promo, confirm the exact cost at checkout. Custom blends also warrant scrutiny on ingredient transparency. Also (found 2026-09-06): the offer page states 'In Nebraska, services are limited to patients 19 years of age or older,' a state-specific age gate on top of the Louisiana exclusion. Worth surfacing if RY ever builds Nebraska-specific copy.
Price checked	Checked by a person July 25, 2026	Checked by a person September 17, 2026 · an automated check re-read it September 21, 2026

When to choose Direct Meds

You want a specific format, injection or sublingual, at a clear all-inclusive price
You're already familiar with GLP-1 dosing and side-effect management
You don't need a coach or a heavy-touch clinical team
You want a no-frills, predictable monthly bill

Check current Direct Meds pricing →

When to choose Embody

You want a compounded program that personalizes the formulation
You're comfortable evaluating ingredient lists and provider transparency
You'd value bundled adjuncts (anti-nausea, B12, etc.) when offered
You're escalating dose and want a provider that adjusts with you

Check current Embody pricing →

Full reviews

Frequently asked questions

Is Direct Meds cheaper than Embody?

Embody starts lower on semaglutide (Compounded, $69/mo (limited-time promo; the offer page shows a 'Was $299' strikethrough and a 'Fall Sale Discount Applied!' banner as of 2026-09-17, with an expired-reading countdown), verified 2026-09-17; confirm current price at checkout). Embody starts lower on tirzepatide (Compounded tirzepatide / GLP-1+GIP, $119/mo (flat pricing shown on the verified offer page), verified 2026-09-17; no 'was' comparison price shown for tirzepatide specifically, confirm at signup.). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, Direct Meds or Embody?

Embody starts lower on both semaglutide and tirzepatide based on listed entry pricing. That said, the right pick is the program whose support model and formulation match what you actually need.

Are Direct Meds and Embody compounded or brand-name?

Direct Meds offers compounded semaglutide and tirzepatide. Embody offers compounded glp-1 with personalization. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Direct Meds to Embody?

Yes, switching between Direct Meds and Embody is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Direct Meds and Embody to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like $249/mo (sublingual) to $297/mo (injection), all-inclusive, verified 2026-07-25 on Direct Meds' own product pages ('$249.00 / month … Billed Every Month', '0% OFF') and Compounded, $69/mo (limited-time promo; the offer page shows a 'Was $299' strikethrough and a 'Fall Sale Discount Applied!' banner as of 2026-09-17, with an expired-reading countdown), verified 2026-09-17; confirm current price at checkout are starting tiers, not your guaranteed long-term cost.